14 research outputs found
Aspectos sorológicos, epidemiológicos e moleculares da infecção pelo vírus da hepatite C na população da região de Londrina, Paraná, Brasil, 2001-2002
Serological, epidemiological and molecular aspects of hepatitis C virus (HCV) infection were evaluated in 183 subjects from Londrina, Paraná, Brazil, and adjacent areas. Serum samples which tested anti-HCV positive by microparticle enzyme immunoassay (MEIA) obtained from eight patients with chronic hepatitis C, 48 blood donors, and 127 patients infected with the human immunodeficiency virus (HIV) were submitted to another enzyme immunoassay (ELISA) and to the polymerase chain reaction (PCR). About 78.7% of samples were also reactive by ELISA, with the greater proportion (70.8%) of discordant results verified among blood donors. A similar finding was observed for HCV-RNA detection by PCR, with 111/165 (67.3%) positive samples, with higher rates among HIV-positive subjects and patients with chronic hepatitis than among blood donors. Sixty-one PCR-positive samples were submitted to HCV genotyping, with 77.1, 21.3 and 1.6% of the samples identified as types 1, 3 and 2, respectively. Finally, analysis of some risk factors associated with HCV infection showed that intravenous drug use was the most common risk factor among HIV/HCV co-infected patients, while blood transfusion was the most important risk factor in the group without HIV infection. The present study contributed to the knowledge regarding risk factors associated with HCV infection and the distribution of HCV genotypes in the population evaluated.Aspectos sorológicos, epidemiológicos e moleculares da infecção pelo vírus da hepatite C (HCV) foram avaliados em 183 indivíduos da região de Londrina, Paraná. Amostras soropositivas para anti-HCV pelo enzimaimunoensaio de micropartículas (MEIA), provenientes de oito pacientes com hepatite C crônica, 48 doadores de sangue e 127 indivíduos infectados pelo vírus da imunodeficiência humana (HIV), foram submetidas ao enzimaimunoensaio (ELISA) e a reação em cadeia da polimerase (PCR). Em 78,7% das amostras, verificou-se resultado reagente no ELISA, ocorrendo maior proporção de resultados discordantes entre doadores de sangue (70,8%). O mesmo ocorreu com a pesquisa do RNA viral, na qual 111/165 (67,3%) amostras foram positivas com PCR, verificando-se maior positividade entre indivíduos HIV soropositivos e pacientes com hepatite crônica do que em doadores de sangue. Em 61 amostras com viremia detectável, realizou-se a genotipagem do HCV, encontrando-se os genótipos 1 (77,1%), 3 (21,3%) e 2 (1,6%). Por fim, foram avaliados os fatores epidemiológicos em indivíduos com infecção ativa, nos quais o uso de drogas injetáveis foi o principal fator de risco encontrado em indivíduos co-infectados pelo HIV/HCV e a transfusão sangüínea foi o mais comum em indivíduos sem infecção pelo HIV. O presente estudo contribuiu para o conhecimento do perfil da infecção pelo HCV em indivíduos da nossa população e da distribuição dos genótipos do HCV nesta região
Evaluation of surrogate markers for human immunodeficiency virus infection among blood donors at the blood bank of "Hospital Universitário Regional Norte do Paraná", Londrina, PR, Brazil
This study evaluated the usefulness of the anti-HBc, hepatitis C virus antibodies (anti-HCV), human T cell lymphotropic virus I and II antibodies (anti-HTLV I/II), serologic tests for syphilis, and surface antigen of hepatitis B virus (HBsAg) as surrogate markers for the risk for HIV infection in 80,284 serum samples from blood donors from the Blood Bank of "Hospital Universitário Regional Norte do Paraná", Londrina, Paraná State, Brazil, analyzed from July 1994 to April 2001. Among 39 blood donors with positive serology for HIV, 12 (30.8%) were anti-HBc positive, 10 (25.6%) for anti-HCV, 1 (2.6%) for anti-HTLV I/I, 1 (2.6%) was positive for syphilis, and 1 (2.6%) for HBsAg. Among the donors with negative serology for HIV, these markers were detected in 8,407 (10.5%), 441 (0.5%), 189 (0.2%), 464 (0.6%), and 473 (0.6%) samples, respectively. The difference was statistically significant (p < 0.001) for anti-HBc and anti-HCV. Although the predictive positive value for these surrogate markers were low for HIV infection, the results confirmed the anti-HBc and anti-HCV as useful surrogate markers for HIV infection thus reinforcing the maintenance of them in the screening for blood donors contributing to the prevention of the small number of cases in which HIV is still transmitted by transfusion.Este estudo avaliou a utilidade dos testes sorológicos para pesquisa de anticorpos anti-antígeno "core" do vírus da hepatite B (anti-HBc), anti-vírus da hepatite C (anti-HCV), anti-vírus linfotrópico de células T humanas tipos I e II (anti-HTLV I/II), testes sorológicos para sífilis e pesquisa do antígeno de superfície do vírus da hepatite B (HBsAg) como marcadores sorológicos indiretos do risco de infecção pelo vírus da imunodeficiência humana (HIV) em 80.284 amostras de soro de doadores de sangue do Hemocentro do Hospital Universitário Regional Norte do Paraná, Londrina, do período de julho de 1994 a abril de 2001. Entre 39 doadores de sangue com sorologia positiva para HIV, 12 (30,8%) apresentaram anti-HBc, 10 (25,6%) anti-HCV, 1 (2,6%) anti-HTLV I/II, 1 (2,6%) sorologia reagente para sífilis, e 1 (2,6%) a presença de HBsAg. Entre os doadores com sorologia negativa para HIV, estes marcadores foram detectados em 8.407 (10,5%), 441 (0,5%), 189 (0,2%), 464 (0,6%), e 473 (0,6%) amostras, respectivamente. A diferença foi estatisticamente significativa (p < 0,001) para anti-HBc e anti-HCV. Embora o valor preditivo positivo para estes marcadores para a infecção pelo HIV foi baixo, os resultados confirmam a importância do anti-HBc e o anti-HCV como marcadores indiretos úteis da infecção por HIV em doadores de sangue e reforçam a sua manutenção na triagem sorológica dos doadores de sangue contribuindo para a prevenção do pequeno número de casos em que o HIV é ainda transmitido por transfusão
Serological, epidemiological and molecular aspects of hepatitis C virus infection in a population from Londrina, PR, Brazil, 2001-2002
Hepatitis C virus infection in a population from Londrina, PR, Brazil: serological, epidemiological and molecular aspects
O objetivo deste trabalho foi avaliar a infecção pelo vírus da hepatite C (HCV) em indivíduos de Londrina e regiões circunvizinhas. Amostras de doadores de sangue e de indivíduos infectados pelo vírus da imunodeficiência humana (HIV) foram analisadas pela metodologia de enzimaimunoensaio de micropartículas (MEIA), obtendo-se a freqüência de positividade para anticorpos anti-HCV de 0,8% e de 20,2%, respectivamente. Um conjunto de 185 amostras soropositivas para anti-HCV pelo MEIA foi submetido a outros testes laboratoriais, para avaliação da correlação entre os diferentes métodos empregados. Apenas 79% destas amostras apresentaram resultado reagente em um segundo teste imunoenzimático (ELISA) empregado, sendo que a maior proporção de resultados discordantes ocorreu entre doadores de sangue. O mesmo ocorreu na pesquisa do RNA viral, onde 111 (67%) das 166 amostras analisadas apresentaram resultado positivo, sendo que a positividade foi maior entre indivíduos HIV soropositivos e pacientes com hepatite crônica do que entre os doadores de sangue. Quinze amostras foram submetidas ao immunoblot (IB), tendo-se obtido resultados positivos neste teste apenas nas amostras reagentes nos dois métodos imunoenzimáticos utilizados. Também pudemos verificar um grande número de amostras com resultado indeterminado no IB, inclusive entre amostras que eram negativas no segundo teste sorológico. Embora a amostragem fosse pequena, com apenas 61 amostras analisadas, a genotipagem do HCV revelou que os genótipos circulantes em nossa região são o tipo 1 (77,1%), seguido do tipo 3 (21,3%) e o tipo 2 (1,6%). Finalmente, avaliamos alguns fatores de risco associados à infecção pelo HCV, sendo que o principal fator de risco encontrado em indivíduos co-infectados pelo HIV/HCV foi o uso de drogas injetáveis, e em indivíduos sem infecção pelo HIV foi a transfusão sangüínea. O presente estudo contribuiu para a avaliação do perfil da infecção pelo HCV em indivíduos da nossa população, permitindo inclusive verificar a distribuição dos genótipos do HCV nesta região.The objective of this work was to evaluate hepatitis C virus (HCV) infection in individuals of Londrina, Paraná State, Brazil, and adjacent areas. Samples of blood donors and individuals infected with Human Immunodeficiency virus (HIV) were analyzed by microparticle enzyme immunoassay (MEIA). Anti-HCV antibody frequency was 0.8% in blood donors, and 20.2% in HIV patients. A group of 185 anti-HCV positive samples by MEIA was submitted to other laboratorial tests, in order to access the correlation among different methods used. Only 79% of samples were reactive by a second antibody-screening test (enzime-linked immunosorbent assay - ELISA), and a great proportion of discordant results was verified among blood donors. The same happened at HCV-RNA detection by polymerase chain reaction (PCR), where 111/166 (67%) of samples showed positive results, which was greater among HIV positive individuals and patients with chronic hepatitis than among blood donors. Only 15 samples were submitted to immunoblot (IB): positive results were obtained only at samples which were also reactive by the two antibody-screening tests used. We could also verify a great number of anti-HCV indeterminate results by IB, which also happened among samples tested negative by the second serologic assay. Although the small number of samples used in genotype determination of HCV, only 61, our data revealed that the circulating genotypes in our region are type 1 (77.1%), followed by type 3 (21.3%) and type 2 (1.6%). Finally, we evaluated some risk factors associated to HCV infection, and we found that intravenous drug use was the most common risk factor among patients HIV/HCV co-infected, while blood transfusion was the most important risk factor in the group without HIV infection. The present study contributed to the evaluation of HCV infection in our population, so that the distribution of HCV genotypes in the region could be accessed
Hepatitis C virus infection in a population from Londrina, PR, Brazil: serological, epidemiological and molecular aspects
O objetivo deste trabalho foi avaliar a infecção pelo vírus da hepatite C (HCV) em indivíduos de Londrina e regiões circunvizinhas. Amostras de doadores de sangue e de indivíduos infectados pelo vírus da imunodeficiência humana (HIV) foram analisadas pela metodologia de enzimaimunoensaio de micropartículas (MEIA), obtendo-se a freqüência de positividade para anticorpos anti-HCV de 0,8% e de 20,2%, respectivamente. Um conjunto de 185 amostras soropositivas para anti-HCV pelo MEIA foi submetido a outros testes laboratoriais, para avaliação da correlação entre os diferentes métodos empregados. Apenas 79% destas amostras apresentaram resultado reagente em um segundo teste imunoenzimático (ELISA) empregado, sendo que a maior proporção de resultados discordantes ocorreu entre doadores de sangue. O mesmo ocorreu na pesquisa do RNA viral, onde 111 (67%) das 166 amostras analisadas apresentaram resultado positivo, sendo que a positividade foi maior entre indivíduos HIV soropositivos e pacientes com hepatite crônica do que entre os doadores de sangue. Quinze amostras foram submetidas ao immunoblot (IB), tendo-se obtido resultados positivos neste teste apenas nas amostras reagentes nos dois métodos imunoenzimáticos utilizados. Também pudemos verificar um grande número de amostras com resultado indeterminado no IB, inclusive entre amostras que eram negativas no segundo teste sorológico. Embora a amostragem fosse pequena, com apenas 61 amostras analisadas, a genotipagem do HCV revelou que os genótipos circulantes em nossa região são o tipo 1 (77,1%), seguido do tipo 3 (21,3%) e o tipo 2 (1,6%). Finalmente, avaliamos alguns fatores de risco associados à infecção pelo HCV, sendo que o principal fator de risco encontrado em indivíduos co-infectados pelo HIV/HCV foi o uso de drogas injetáveis, e em indivíduos sem infecção pelo HIV foi a transfusão sangüínea. O presente estudo contribuiu para a avaliação do perfil da infecção pelo HCV em indivíduos da nossa população, permitindo inclusive verificar a distribuição dos genótipos do HCV nesta região.The objective of this work was to evaluate hepatitis C virus (HCV) infection in individuals of Londrina, Paraná State, Brazil, and adjacent areas. Samples of blood donors and individuals infected with Human Immunodeficiency virus (HIV) were analyzed by microparticle enzyme immunoassay (MEIA). Anti-HCV antibody frequency was 0.8% in blood donors, and 20.2% in HIV patients. A group of 185 anti-HCV positive samples by MEIA was submitted to other laboratorial tests, in order to access the correlation among different methods used. Only 79% of samples were reactive by a second antibody-screening test (enzime-linked immunosorbent assay - ELISA), and a great proportion of discordant results was verified among blood donors. The same happened at HCV-RNA detection by polymerase chain reaction (PCR), where 111/166 (67%) of samples showed positive results, which was greater among HIV positive individuals and patients with chronic hepatitis than among blood donors. Only 15 samples were submitted to immunoblot (IB): positive results were obtained only at samples which were also reactive by the two antibody-screening tests used. We could also verify a great number of anti-HCV indeterminate results by IB, which also happened among samples tested negative by the second serologic assay. Although the small number of samples used in genotype determination of HCV, only 61, our data revealed that the circulating genotypes in our region are type 1 (77.1%), followed by type 3 (21.3%) and type 2 (1.6%). Finally, we evaluated some risk factors associated to HCV infection, and we found that intravenous drug use was the most common risk factor among patients HIV/HCV co-infected, while blood transfusion was the most important risk factor in the group without HIV infection. The present study contributed to the evaluation of HCV infection in our population, so that the distribution of HCV genotypes in the region could be accessed
Safety of monitoring antiretroviral therapy response in HIV-1 infection using CD4+ T cell count at long-term intervals
Abstract: The latest Brazilian guideline recommended the reduction of routine CD4+ T cell counts for the monitoring of patients with human immunodeficiency virus type 1 (HIV-1) under combination antiretroviral therapy (cART). The aim of this study was to evaluate the safety of monitoring response to cART in HIV-1 infection using routine viral load at shorter intervals and CD4+ T cell count at longer intervals. CD4+ T cell counts and HIV-1 viral load were evaluated in 1,906 HIV-1-infected patients under cART during a three-year follow-up. Patients were stratified as sustained, non-sustained and non-responders. The proportion of patients who showed a CD4+ T > 350cells/µL at study entry among those with sustained, non-sustained and non-responders to cART and who remained with values above this threshold during follow-up was 94.1%, 81.8% and 71.9%, respectively. HIV-1-infected patients who are sustained virologic responders and have initial CD4+ T cell counts > 350cells/µL showed a higher chance of maintaining the counts of these cells above this threshold during follow-up than those presenting CD4+ T ≤ 350cells/µL (OR = 39.9; 95%CI: 26.5-60.2; p 350cells/µL were more likely to maintain CD4+ T cell counts above this threshold during the next three-year follow-up. This result underscores that the evaluation of CD4+ T cell counts in longer intervals does not impair the safety of monitoring cART response when routine viral load assessment is performed in HIV-1-infected patients with sustained virologic response
Effectiveness of confidential unit exclusion in screening blood donors of the regional blood bank in Londrina, Paraná State
BACKGROUND: For transfusion purposes, blood donors must be accepted both in clinical and serological evaluations and must not have excluded their own donation using the confidential unit exclusion. AIMS: The objective of this study was to verify whether blood donors who choose self exclusion are more likely to be positive in serological tests than donors who do not. METHODS: A cross-sectional analysis was carried out of 51,861 consecutive whole blood donations from January 2004 to December 2008 at a public blood bank in Londrina, Southern Brazil. RESULTS: Self exclusion was chosen in 1672 (3.2%) donations, most frequently by first-time blood donors (p-value < 0.0001), by blood donors from external collections (p-value < 0.0001), by men (p value < 0.0001) and by under 30-year-old donors (p-value < 0.0001). The frequency of positive serology was 5.3% in the group that chose self exclusion and 3.5% in the group that did not choose self exclusion (p-value < 0.0001). CONCLUSIONS: These results show that confidential unit exclusion used in this blood bank is effective and is inexpensive. However, the diagnostic power to detect blood-borne infections was low and resulted in the discard of a high number of blood bags without any direct or indirect serologic markers of pathogens. The use of confidential unit exclusion could be replaced with molecular tests to screen blood donors
Frequency of the changes in the serum immunoglobulins levels of the patients attended at the University Hospital, Londrina, Paraná <br> Freqüência das alterações dos níveis séricos de imunoglobulinas dos pacientes atendidos no Hospital Universitário, Londrina, Paraná
The immunoglobins constitute a group of glycoproteins detected in the serum and body fluids and are produced by the B-activated lymphocytes that are differentiated in the plasma cells. They are divided into five distinct classes or isotypes: IgG, IgA, IgM, IgD, and IgE. The aim of this study was to evaluate the frequency of changes in the serum levels of immunoglobins in patients attended at the University Hospital (HU), in Londrina, Paraná, assayed during the period from August 2001 to February 2006, by the nephelometry method. The immunoglobin levels were evaluated in 773 serum samples: 410 samples (53.0%) were from female patients and 363 (47.0%) from male patients, with ages ranging from one month to 86 years old. Among the 1719 serum evaluations, the IgA was evaluated in 568 serum samples and changes were observed in 88 (15.5%) of them. Among 495 IgG evaluations, 107 (21.6%) showed changes in the serum levels. The IgM was evaluated in 465 serum samples and 142 (30.5%) showed increased levels. The IgE was evaluated in 191 samples and 129 (67.5%) presented increased serum levels. The results obtained confirm the occurrence of different changes in the serum immunoglobin levels and the importance of this laboratory evaluation for the diagnosis of the infectious, allergic, and autoimmune diseases, and the congenital or acquired humoral immunodeficiencies. <p><p>As imunoglobulinas constituem um grupo de glicoproteínas presentes no soro e nos líquidos orgânico se são produzidas pelos linfócitos B ativados que se diferenciam em plasmócitos. São divididas em cinco classes ou isotipos: IgG, IgA, IgM, IgD e IgE. O objetivo deste trabalho foi determinar a freqüência das alterações dos níveis séricos das imunoglobulinas nos pacientes atendidos pelo Hospital Universitário (HU), Londrina, PR, no período de agosto de 2001 a fevereiro de 2006, avaliados pelo método de nefelometria. Foram analisadas 773 amostras de soro de pacientes, 410 (53,0%) do sexo feminino e 363 (47,0%) do sexo masculino, com idade variando de um mês a 86 anos. Das 1719 dosagens de imunoglobulinas séricas realizadas, os níveis de IgA sérica foram avaliados em 568 amostras e foram observadas alterações em 88 (15,5%) das amostras. Das 495 dosagens de IgG, 107 (21,6%) estavam com os níveis séricos alterados. A dosagem de IgM sérica foi realizada em 465 amostras e 142 (30,5%) estavam com os níveis séricos alterados. Os níveis de IgE sérica foram avaliados em 191 amostras e 129 (67,5%) amostras apresentaram níveis aumentados. Os dados obtidos confirmam a ocorrência de diferentes alterações nos níveis séricos das imunoglobulinas e a importância destas dosagens laboratoriais no diagnóstico de doenças infecciosas, parasitárias, alérgicas, auto-imunes e das imunodeficiências humorais congênitas ou adquiridas. <!--[if !supportEmptyParas]--